Economics ❯Market Trends

Pharmaceutical Market

Drug Sales Investment Strategies Investment Opportunities Revenue Decline Drug Demand Drug Pricing Stock Performance Sales Performance Competition COVID-19 Impact Generics

Biontech Reports Q1 Loss as Focus Shifts to mRNA Cancer Therapies

The company announces a €415.8 million net loss, lowers 2025 revenue forecast, and targets its first oncology approval by 2026.

Merck in Advanced Talks to Acquire Springworks Therapeutics for $3.5 Billion

Eli Lilly's Mounjaro Launches in India, Targeting Obesity and Diabetes

Biontech Reports €700 Million Loss and Plans Workforce Restructuring

Novo Nordisk Reports Doubling Wegovy Sales, Projects Slower Growth in 2025

Merck to Acquire EyeBio for Up to $3 Billion